Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933



 Company News
Catalyst Pharmaceuticals (CPRX) Announces Fourth Quarter And Year-End 2014 Financial Results 3/16/2015 7:55:10 AM
Catalyst Pharmaceuticals (CPRX) To Present At The 27th Annual ROTH Conference 3/9/2015 8:09:01 AM
Catalyst Pharmaceuticals (CPRX) Announces FDA Orphan Drug Designation Of Firdapse For Treatment Of Congenital Myasthenic Syndromes 3/5/2015 9:30:06 AM
Catalyst Pharmaceuticals (CPRX) Announces Appointment Of Richard J. Daly And Donald A. Denkhaus To Its Board Of Directors 2/19/2015 12:49:18 PM
Catalyst Pharmaceuticals (CPRX) Announces Closing Of Previously Announced Public Offering 2/9/2015 10:37:00 AM
Catalyst Pharmaceuticals (CPRX) Prices Public Offering Of Common Stock 2/4/2015 7:43:57 AM
Catalyst Pharmaceuticals (CPRX) Announces Commencement Of Public Offering Of Common Stock 2/4/2015 7:42:50 AM
Catalyst Pharmaceuticals (CPRX) Announces Encouraging Pre-NDA Meeting With The FDA For Firdapse™ As A Treatment For Lambert-Eaton Myasthenic Syndrome (LEMS) 2/2/2015 8:08:29 AM
Catalyst Pharmaceuticals (CPRX) Provides An Update Of 2015 Goals For Its Product Portfolio 1/12/2015 7:23:52 AM
Catalyst Pharmaceuticals (CPRX) Appoints David D. Muth, Executive Vice President, Chief Commercial Officer 1/5/2015 7:15:10 AM